Rachel L. Nosheny, Ph.D.
Affiliations: | 2006 | Georgetown University Medical Center, Washington, DC, United States |
Area:
Neuroscience Biology, Virology BiologyGoogle:
"Rachel Nosheny"Mean distance: 53433
Parents
Sign in to add mentor| Italo Mocchetti | grad student | 2006 | Georgetown University Medical Center | |
| (The neuroprotective effect of brain -derived neurotrophic factor against human immunodeficiency virus type-1 glycoprotein 120-mediated neurotoxicity in the basal ganglia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nosheny RL, Jin C, Neuhaus J, et al. (2019) Study partner-reported decline identifies cognitive decline and dementia risk. Annals of Clinical and Translational Neurology |
| Camacho MR, Grill JD, Karlawish J, et al. (2019) P1-351: COGNITIVELY IMPAIRED BRAIN HEALTH REGISTRY PARTICIPANTS’ ATTITUDES ABOUT THE VALUE OF AMYLOID PET RESULTS Alzheimer's & Dementia. 15: P385-P385 |
| Weiner MW, Nosheny RL, Mackin RS, et al. (2019) S4-01-01: IDENTIFYING ELDERS AT RISK FOR COGNITIVE DECLINE USING THE BRAIN HEALTH REGISTRY (BHR) Alzheimer's & Dementia. 15: P1215-P1215 |
| Mackin RS, Insel PS, Truran D, et al. (2018) Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 573-582 |
| Nosheny RL, Camacho MR, Insel PS, et al. (2018) Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimer's & Dementia (New York, N. Y.). 4: 565-574 |
| Zwan MD, Flenniken D, Finley S, et al. (2017) [P2-052]: THE DUTCH BRAIN HEALTH REGISTRY: OPTIMIZING RECRUITMENT FOR DEMENTIA RESEARCH Alzheimer's & Dementia. 13: P624-P624 |
| Nosheny RL, Flenniken D, Insel PS, et al. (2016) P4-005: SELF-REPORTED APOE GENOTYPE IN THE BRAIN HEALTH REGISTRY: ASSOCIATIONS WITH MEMORY AND ASSESSMENT OF APOE 4+ PARTICIPANTS ELIGIBLE FOR ALZHEIMER'S DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 12: P1015-P1016 |
| Insel PS, Mattsson N, Mackin RS, et al. (2015) Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Annals of Clinical and Translational Neurology. 2: 534-47 |
| Nosheny RL, Insel PS, Truran D, et al. (2015) Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiology of Aging. 36: 273-82 |
| Nosheny RL, Flennkiken D, Insel PS, et al. (2015) O1-10-06: Internet-based recruitment of subjects for prodromal and secondary prevention Alzheimer's disease trials using the brain health registry Alzheimer's & Dementia. 11: P156-P156 |